NATIONAL CANCER INSTITUTE - CANCER.GOV

Contact Information


Primary Contact

Alan K. Jarmusch, Ph.D.
Director

Location

111 TW Alexander Dr
David P Rall Building
Research Training Park, NC 27709

Additional Contacts

Benjamin (Benji) Schwarz, Ph.D.
MetLip Unit Group Leader
Michael B. Fessler, M.D.
Chief
Ruin Moaddel
Staff Scientist

Overview

The NIH Metabolomics Consortium (NIH-MC) is a shared research resource that performs metabolomics analysis (and related small molecule research) for investigators at all Institutes and Centers across the NIH Intramural Research Program. The NIH-MC is administered at NIEHS with participating laboratories at NIEHS, NIA, and NIAID. The NIH-MC was established in 2023, by the SRS Subcommittee of the Scientific Directors, and continues to grow in the offerings provided, expertise, and participatory labs.

Established Technologies
Metabolomics measures the small molecules – endogenous and exogenous – that underpin biological changes in response to diet, behavior, exposure, disease, and more. Currently, the NIH-MC offers two general types of metabolomics approaches – targeted and untargeted – covering different aspects of metabolism and to varying degrees of analytical measurement. Each offering has unique requirements, deliverables, and costs – please review the information for each offering carefully. The specific metabolomics assays offered, by site, are:

National Institute on Aging (NIA)

National Institute of Allergy and Infectious Disease (NIAID)

  • Bile Acids – Quantification of primary and secondary bile acids, including conjugated and free forms.
  • Short Chain Fatty Acids – Quantification of short-chain fatty acids (consult prior to sample collection).
  • Targeted Lipidomics – Relative quantitation of a broad panel of >1700 individual glycerolipid, sphingolipid, and sterol lipids.
  • Oxidized immune lipid mediators

National Institute of Environmental Health Sciences (NIEHS)

  • Untargeted Metabolomics – Measurement of the relative changes of all detectable chemicals/metabolites in a specimen as part of a global metabolic profile.
  • Glutathione and metabolites panel (Gamma-glutamylcysteine, glutathione, and glutathione disulfide)
  • Chlorpyrifos and metabolites panel (Chlorpyifos, Chlorpyrifos-oxon, and 3,5,6-trichloro-2-pyridinol)
  • *coming soon* Mass Spectrometry Imaging for Spatial Lipidomics or Metabolomics
Pricing

Cost varies across assays but is highly competitive with academic laboratories and commercial services. Cost will be discussed and agreed upon prior to starting the project. Different NIH Institutes/Centers handle Investigator costs for core facilities using different mechanisms, so we recommend that you inquire with your Lab/Branch Chief or Scientific Director.

User Guidelines

  1. Submit a request form (information below) or email a general inquiry.
  2. A request form is required prior to consideration.
  3. The NIH Metabolomics Consortium (NIH-MC) team will review the request and discuss feasibility.
  4. The NIH-MC team will contact the requester and PI to determine all further steps, which nearly always include a consultation via video conference, guidance on sample handling and/or preparation, and so on.
  5. Note: The participating laboratory may determine after consultation that it cannot provide the requested analysis. The NIH-MC will assist in finding alternative options.

Keywords

Mass SpectrometryMetabolomicsMetabolomics Data AnalysisUntargetedUntargeted MetabolomicsLipidomicsLipidsQuantitative Analysis